Zoetis sues rival over generic pet vomiting treatment
Veterinary drug maker Dechra’s generic of a drug that treats vomiting in dogs and cats, Cerenia (Maropitant), infringes a patent owned by its competitor Zoetis, a new lawsuit has alleged.
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk
4 May 2018 The US Court of Appeals for the Federal Circuit has confirmed that individuals need not have contributed equally to be considered joint inventors of patentable subject matter, in a case involving a dog mobility device.
4 May 2018 The US Court of Appeals for the Federal Circuit has confirmed that individuals need not have contributed equally to be considered joint inventors of patentable subject matter, in a case involving a dog mobility device.
4 May 2018 The US Court of Appeals for the Federal Circuit has confirmed that individuals need not have contributed equally to be considered joint inventors of patentable subject matter, in a case involving a dog mobility device.
